EBV-positive tumor cells can release EBV-encoded RNAs, EBER1, EBER2, miRNAs and the LMP-1 protein via exosomes allowing the RNAs and/or proteins to be captured by EBV-negative bystander cells, such as follicular DCs, and can then be presented by these APCs to other EBV-negative immune cells thereby inhibiting their activation [220]. This evidence concerns the gene PDLIM7 and neoplasm.